Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AXNX

Axonics (AXNX) Stock Price, News & Analysis

Axonics logo

About Axonics Stock (NASDAQ:AXNX)

Advanced Chart

Key Stats

Today's Range
$70.98
$70.98
50-Day Range
$69.66
$70.98
52-Week Range
$67.27
$71.05
Volume
N/A
Average Volume
423,430 shs
Market Capitalization
$3.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Receive AXNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axonics and its competitors with MarketBeat's FREE daily newsletter.

AXNX Stock News Headlines

Axonics Modulation Technologies Merges and Delists from Nasdaq
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Boston Scientific Closes Acquisition of Axonics, Inc.
See More Headlines

AXNX Stock Analysis - Frequently Asked Questions

Axonics, Inc. (NASDAQ:AXNX) released its earnings results on Thursday, November, 7th. The company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.11 by $0.05. The firm's revenue was up 24.8% on a year-over-year basis.

Axonics (AXNX) raised $100 million in an IPO on Wednesday, October 31st 2018. The company issued 6,700,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Morgan Stanley served as the underwriters for the IPO and Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Axonics investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), NVIDIA (NVDA), TotalEnergies (TTE) and The RMR Group (RMR).

Company Calendar

Last Earnings
11/07/2024
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AXNX
Employees
610
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
322.64
P/E Growth
N/A
Net Income
-$6.09 million
Pretax Margin
-0.70%

Debt

Sales & Book Value

Annual Sales
$366.38 million
Cash Flow
$0.13 per share
Price / Cash Flow
561.96
Book Value
$12.59 per share
Price / Book
5.64

Miscellaneous

Free Float
50,163,000
Market Cap
$3.63 billion
Optionable
Optionable
Beta
0.82
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:AXNX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners